BTG3 overexpression suppressed the proliferation and invasion of epithelial ovarian and colorectal cancer cells by weakening Akt/GSK3β/β-catenin signaling (Mao et al., 2016; An et al., 2017). Here, BTG3 is linked to colorectal cancer.